Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Sevelamer hydrochloride (Renagel) and ferric citrate (Auryxia) are both phosphate binders used to lower high blood phosphate levels in people with chronic kidney disease (CKD) on dialysis. However, they have some key differences. Sevelamer hydrochloride is only available in tablet form and must be taken with meals. It does not affect calcium levels in your body unlike other medications that lower high phosphate levels. On the other hand, ferric citrate is also taken with meals and must be swallowed whole, but it contains iron, making it an option for treating iron deficiency anemia. Due to the iron component of ferric citrate, your stools may look darker and may lead to iron overload if not monitored properly. This is not a concern with sevelamer hydrochloride. Both medications require frequent blood tests to adjust dosing. Ferric citrate can interact with certain antibiotics, so you need to be careful about timing when taking these medications together.
Sevelamer hydrochloride (Renagel)
Auryxia (ferric citrate)
Sevelamer hydrochloride (Renagel)
Auryxia (ferric citrate)
Summary of Renagel vs. Auryxia
Summary for Phosphate binder
Prescription only
Sevelamer hydrochloride, commonly known by its brand name Renagel, helps treat high phosphate levels in the blood (hyperphosphatemia) in adults with chronic kidney disease (CKD) who are receiving dialysis. This medication is a phosphate binder. It attaches to phosphate in food so it's not absorbed into your blood. Sevelamer hydrochloride (Renagel) comes as tablets that are taken by mouth three times per day with meals. Common side effects include nausea, vomiting, and diarrhea. This medication is available as a generic.
Summary for Phosphate binder
Prescription only
Auryxia (ferric citrate) is a phosphate binder used to treat high phosphorus levels (hyperphosphatemia) in adults with chronic kidney disease (CKD) on dialysis. It's also used as an iron supplement to treat iron-deficiency anemia (IDA) in adults with CKD who aren't on dialysis. Auryxia (ferric citrate) comes as a 210 mg tablet and is taken by mouth three times per day with meals. It's not available as a generic. Common side effects include dark stools, diarrhea, and constipation.